HPV Vaccine Catch-Up for Women Aged 27–45: 2026 Evidence Update

The short answer: Yes, women aged 27–45 can still have the HPV vaccine, but the benefit is smaller than in young girls. It protects against HPV types you have not already caught, so it helps most if you are unlikely to have met those types before. It does not treat an existing infection and does not replace cervical screening. At this age it is a personal decision to make with your doctor, not a routine recommendation for every woman.

Many women search for this as HPV vaccine after marriage, HPV vaccine age limit or HPV vaccine kab lagta hai (एचपीवी वैक्सीन कब लगता है). The vaccine was first aimed at girls aged 9–14, before any exposure to the virus.

On this page

• Who is eligible for catch-up
• What the evidence shows
• Dose schedule and cost
• What the vaccine does NOT do
• How to get it in Ahmedabad

Who is eligible for catch-up?

There is no strict cut-off, but advice changes with age. In the United States, the national vaccine advisory committee (ACIP, 2019) recommends catch-up vaccination for everyone up to age 26. For adults aged 27–45 it does not recommend routine vaccination; instead it suggests a shared decision between the woman and her doctor, because some women in this age group may still be at risk of new HPV infection and could benefit (Meites et al., MMWR 2019, doi:10.15585/mmwr.mm6832a3). Your doctor will consider your age, past Pap or HPV results and the chance of new exposure before advising you.

India’s national programme: since 28 February 2026, girls aged 14 can get a free single dose of the HPV vaccine (Gardasil-4) at government health facilities. Women aged 27–45 are not covered by this programme and usually get the vaccine privately.

What does the evidence show?

The benefit is smaller than when the vaccine is given before any exposure, but it is real for women who are not already infected. In the main trial in women aged 24–45 (the FUTURE III trial, which used the 4-type vaccine), protection against infection and cell changes caused by the vaccine HPV types was about 90% in women who were not already infected with those types. Across all women in the trial, including those already infected, protection was only about 31%, because the vaccine cannot clear an infection you already have (Muñoz et al., Lancet 2009, doi:10.1016/S0140-6736(09)60691-7). Results at the end of the study, after about 4 years, were similar: about 89% in women not already infected (Castellsagué et al., Br J Cancer 2011, doi:10.1038/bjc.2011.185). For the 9-type vaccine, a study in women aged 27–45 found antibody levels comparable to those in women aged 20–26 (Lv et al., Vaccine 2022, doi:10.1016/j.vaccine.2022.02.061); this measures the immune response, not cancer prevention directly.

Dose schedule and cost

For ages 15 and above, the 9-valent vaccine is given in a 3-dose schedule (0, 2, 6 months). Cost in India ranges Rs 3,000–6,000 per dose depending on brand and pharmacy. Many corporate health-insurance policies do not yet cover adult HPV vaccination; it is typically self-paid.

What the vaccine does NOT do

• Does not treat existing HPV infection or precancerous lesions.
• Does not cover every high-risk HPV type — screening (Pap smear or HPV DNA test) is still essential; see cervical screening and prevention.
• Does not protect against established cervical cancer in any way.

How to get HPV vaccination in Ahmedabad

HPV vaccines are available at most large pharmacies, gynaecologist clinics, and hospital vaccination centres in Ahmedabad. Dr. Nishtha advises patients on suitability based on HPV history, screening status, and age. WhatsApp +91 76988 00333 for a brief consult.

External: WHO HPV Vaccine Information. See also our HPV infection page.

FAQs

Reviewed by Dr. Nishtha Tripathi Patel, MBBS, DGO, DNB, Fellowship Gynaecological Oncology, ESGO-certified. For consultations: WhatsApp +91 76988 00333.